OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
September 02, 2021
Alternative materials, as well as supply-chain planning, are essential to ensure a reliable supply for parenteral drug packaging.
August 25, 2021
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 01, 2021
Scenario modeling informs planning for current and future manufacturing needs.
June 30, 2021
Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024.
June 01, 2021
Container and equipment innovations expand applications.
May 25, 2021
The new line can fill prefilled syringes, cartridges, and vials using ready-to-use components.
May 24, 2021
Samsung Biologics plans to support the production of hundreds of millions of doses of Moderna’s vaccine to supply to markets outside of the United States beginning in the third quarter of 2021.
May 10, 2021
BioNTech plans to expand its global footprint by establishing its regional headquarters for southeast Asia and a new mRNA manufacturing facility in Singapore.
May 01, 2021
A best practices approach to pharma’s most challenging-to-inspect container.
April 29, 2021
Moderna’s investments will double the formulation fill/finish and drug substance manufacturing of its vaccine to up to three billion doses in 2022 at various manufacturing sites.